Asian Pacific Journal of Tropical Biomedicine
Teicoplanin is a potential inhibitor of SARS CoV-2 replication enzymes: A docking study
Author:
Affiliation:

Clc Number:

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Objective: To explore potential inhibitors of viral enzymes of SARS CoV-2. Methods: The in-silico docked potential of anti-viral, antibiotic, and analgesic drugs were studied for inhibition of the nonstructural protein (NSP) 9, NSP3, and NSP15 of SARS CoV-2 using recent structural peculiarities of these enzymes, 3D optimized structures of drugs and algorithm-based ligand inhibitory potential. Results: Teicoplanin, azithromycin, and remdesivir potentially inhibited NSP9 (Dock-score 9 620, 5 472 and 6 252, respectively), NSP3 (Dock-score 9 846, 5 604 and 5 548, respectively) and NSP15 (Dock-score 10 960, 6 414 and 6 002, respectively). Conclusions: Teicoplanin acts as a significant receptor antagonist and potentially inhibits the SARS CoV-2 enzymes.

    Reference
    Related
    Cited by
Get Citation

Sadia A, Azam M, Basra MAR. Teicoplanin is a potential inhibitor of SARS CoV-2 replication enzymes: A docking study. Asian Pac J Trop Biomed 2020; 10(12): 563-568.

Copy
分享
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:April 19,2020
  • Revised:May 05,2020
  • Adopted:June 20,2020
  • Online: October 19,2020
  • Published:

Academic misconduct statement

    Peer review

    WeChat

    Mobile website

    Close